Medical Journals Publishing
Login


International Journal of Cognitive Neuroscience and Psychology

 Submit manuscript

COMPREHENSIVE USE OF THE MOCA TEST AND ARTERIAL PRESSURE MONITORING AS A METHOD FOR EARLY DETECTION OF DISCIRCULATORY ENCEPHALOPATHY IN AMBULATORY CONDITIONS

Vol. 4 No. 1 (2026): International Journal of Cognitive Neuroscience and Psychology:
Published : Jan 10, 2026

Djurabekova Aziza Takhirovna (1), Abdullayeva Nargiza Nurmamatovna (2), Kazakova Lobar Farkhod Kizi (3)

(1) Doctor of Medical Sciences, Professor, Head of the Department of Neurology, Samarkand State Medical University, Uzbekistan
(2) Doctor of Medical Sciences, Professor of the Department of Neurology, Samarkand State Medical University, Uzbekistan
(3) Master of the Department of Neurology, Samarkand State Medical University, Uzbekistan
Fulltext View | Download

Abstract:

Dyscirculatory encephalopathy (DE) is one of the most pressing problems in modern neurology and gerontology, characterized by progressive brain damage due to chronic cerebrovascular insufficiency. According to the World Health Organization, cerebrovascular diseases rank third among causes of death and are the leading cause of disability among adults in developed countries.

References

1. Astashkin E.I., Glezer M.G. Arterial Hypertension and Brain Damage. Cardiology. 2021;61 (4):78-85.

2. Vereshchagin N.V., Piradov M.A. Chronic forms of cerebrovascular insufficiency. Journal of Neurology and Psychiatry named after S.S. Korsakov. 2020;120 (6):4-10.

3. Damulin I.V. Circulatory encephalopathy: modern approaches to diagnosis and treatment. Neurological Journal. 2021;26 (2):5-12.

4. Jurabekova A.T., Khamraev Kh.A. Chronic cerebrovascular disorders: clinical and diagnostic aspects. Journal of Theoretical and Clinical Medicine. 2022; 6:34-38.

5. Yodgarova N.A., Raimova Sh.B. Features of diagnosing dyscirculatory encephalopathy at the outpatient stage. Problems of Biology and Medicine. 2023.4:96-100.

6. Parfenov V.A. Vascular cognitive impairments: diagnosis and treatment. Neurology, neuropsychiatry, psychosomatics. 2021;13 (3):4-9.

7. Rakhimbayeva G.S., Gaziyeva Sh.R. Cognitive impairments in chronic cerebrovascular disorders. Medical Express. 2024;5:22-27.

8. Salohiddinova Sh.R. Neurological aspects of vascular pathology of the brain. Bulletin of Samarkand State Medical University. 2019; 3:41-45.

9. Skvorsova V.I., Stahovskaya L.V. Prevention of Cerebrovascular Diseases. Annals of clinical and experimental neurology. 2019;13 (1):5-14.

10. Brookes R.L., Hannesdottir K., Markus H.S. Brief cognitive assessment for vascular cognitive impairment. Stroke. 2016;47 (1):248-253.

11. Dichgans M., Leys D. Vascular cognitive impairment. Circulation Research. 2017; 120 (3): 573-591.

12. Quinn T.J., Elliott E., Langhorne P. Cognitive and mood assessment tools for use in stroke and TIA. International Journal of Stroke. 2018;13 (7):653-665.

13. Rundek T., Sacco R.L. Risk factor management to prevent first stroke. Neurology Clinics. 2022;40 (2):255-268.

14. Smith E.E. Prevention of stroke and dementia with blood pressure control. Journal of the American College of Cardiology. 2020;75 (15):1804-1818.

15. Smith E.E., Markus H.S. New treatment approaches to modify the course of cerebrovascular diseases. Stroke. 2020;51 (1):38-46.

16. Wardlaw J.M., Smith C., Dichgans M. Small vessel disease: mechanisms and clinical implications. The Lancet Neurology. 2019;18 (7): 684-696.

17. Wardlaw J.M., Valdés Hernández M.C., Muñoz-Maniega S. What are white matter hyperintensities made of? Journal of the American Heart Association. 2015;4 (6):e001140.